Active substance: methylethylpyridinol

Brief description:the drug has an antihypoxic effect, strengthens the vascular wall, reduces capillary permeability, inhibits platelet aggregation.


Additional information:

Drug indication:

- treatment and prevention of corneal inflammation and burns;

- treatment of hemorrhages in the anterior chamber of the eye;

- treatment and prevention of hemorrhages in the sclera in the elderly;

- thrombosis of the central retinal vein and its branches;

- treatment of myopia complications;

- treatment of myopia complications;

Drug effects: The drug reduces the permeability of capillaries, strengthens the vascular wall, stabilizes the cell membrane, inhibits platelet aggregation, reduces blood clotting and viscosity, has antiaggregational and antihypoxic effects.

Composition: methylethylpyridinol hydrochloride, sodium hyaluronate.

Form of production: 1% eye drops. 5 ml or 10 ml each in a bottle